𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Activation of protein kinase C prevents induction of apoptosis by geranylgeraniol in human leukemia HL60 cells

✍ Scribed by Yutaka Masuda; Madoka Yoda; Hidekazu Ohizumi; Toshihiro Aiuchi; Masahiko Watabe; Shigeo Nakajo; Kazuyasu Nakaya


Publisher
John Wiley and Sons
Year
1997
Tongue
French
Weight
263 KB
Volume
71
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


In a previous study, we showed that geranylgeraniol (GGO) is a potent inducer of apoptosis in human leukemia cells, including HL60 promyelocytic leukemia cells. The present study describes the effects of activators of protein kinase C (PKC) on GGO-induced apoptosis in various lines of leukemia cells. Both 12-O-tetradecanoylphorbol-13-acetate (TPA) and diacylglycerol (DG) inhibited the GGO-induced morphological changes that are characteristic of apoptosis and the DNA fragmentation. Similar effects were observed with other lines of human and murine leukemia cells such as ML1, U937, M1 and P388. Flow cytometric analysis also revealed that both TPA and DG prevented GGO-induced DNA degradation in a dose-dependent manner. These inhibitory effects of TPA and DG were antagonized by inhibitors of PKC such as H-7 and staurosporin, and by amiloride, an inhibitor of Na 1 /H 1 antiporter. In contrast to the inhibitory effects of TPA and DG on GGO-induced apoptosis, 4a-TPA, which is unable to activate PKC, failed to prevent GGO-induced DNA fragmentation. However, the selective activator of PKC-b, 12-deoxyphorbol 13-phenylacetate 20-acetate, significantly inhibited GGOinduced DNA fragmentation. Our results suggest that PKC, and in particular the PKC-b isoenzyme, might be involved in the process of GGO-induced apoptosis.


πŸ“œ SIMILAR VOLUMES


Regulation of G1/S transition and induct
✍ Anna M. Dipietrantonio; Tze-chen Hsieh; Susan C. Olson; Joseph M. Wu πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 French βš– 200 KB πŸ‘ 1 views

We previously reported that all-trans retinoic acid (RA) and fenretinide (4HPR) suppress HL-60 leukemia cell growth and cause partial cell arrest in the G 1 -to-S phase. Moreover, 4HPR but not RA induces apoptosis in HL-60 cells. To investigate further the observed biological effects, cyclin D1 and

Involvement of activator protein-1 (AP-1
✍ Bihong Zhao; Weiping Yu; Ming Qian; Marla Simmons-Menchaca; Powel Brown; Michael πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 244 KB πŸ‘ 1 views

The purpose of this study was to document induction of apoptosis by vitamin E succinate (VES; RRR-Ξ±-tocopheryl succinate) in human breast cancer cells in culture and to characterize potential c-jun involvement. VES at 18.8 Β΅M (10 Β΅g/mL) induced DNA synthesis arrest, reduced total cell numbers, and i

2-deoxyglucose inhibits chemotheapeutic
✍ Naomi Haga; Mikihiko Naito; Hiroyuki Seimiya; Akihiro Tomida; Jian Dong; Takashi πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 French βš– 119 KB πŸ‘ 1 views

Human monocytic leukemia U937 cells undergo apoptosis when treated with antitumor drugs, such as etoposide, camptothecin and mitomycin C. The molecular mechanism of the drug-induced apoptosis is not well understood. In this study, we found that 2-deoxyglucose (2DG), an analog of D-glucose and an ind

RRR-Ξ±-tocopheryl succinate induction of
✍ Weiping Yu; Marla Simmons-Menchaca; Huihong You; Powel Brown; Michael J. Birrer; πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 167 KB

We have demonstrated that RRR-Ξ±-tocopheryl succinate (10 Β΅g/mL vitamin E succinate (VES) treatment of estrogen receptor-negative MDA-MB-435 human breast cancer cells induces 9, 19, 51, and 72% apoptotic cells on days 1-4, respectively, after treatment, which involves transforming growth factor-Ξ² sig

Suppression of proline-directed protein
✍ Chih-Ping Hsu; Chuan-Ching Yang; Sheng-Fen Hsueh M.S.; Chien-Chung Peng B.S.; Hs πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 125 KB

## BACKGROUND. Previously, the authors reported that specific antisense suppression of overexpressed proline-directed protein kinase (PDPK) F A enhances the chemosensitivity of various clinical anticancer drugs up to ΟΎ 100-fold in human prostate carcinoma cells, suggesting an association of PDPK F